Small Molecule Inhibitors of Sec61 Cotranslational Translocation Regulate Phagocytosis Checkpoint Molecule CD47
SITC 35th Anniversary Meeting
Treatment of SLE With or Without Nephritis With the Immunoproteasome Inhibitor KZR-616: Updated Results of the MISSION Study
American College of Rheumatology (ACR) Convergence 2020
KZR-616, a First-in-class Selective Inhibitor of the Immunoproteasome, Ameliorates Polymyositis in a Murine Model
American College of Rheumatology (ACR) Convergence 2020
Blockade of Cytokine Production and Attenuation of Experimental Arthritis Progression by Novel Small Molecule Inhibitors of Sec61-Dependent Protein Secretion
8th Annual Meeting of the International Cytokine & Interferon Society (Cytokines 2020)
KZR-616, A Selective Inhibitor of the Immunoproteasome: Preclinical and Clinical Mechanism of Action Studies in Lupus Nephritis
American Society of Nephrology (ASN Kidney Week) 2020
ASN 2020: Treatment of SLE With or Without Nephritis With the Immunoproteasome Inhibitor KZR-616: Initial Results of the MISSION Study
American Society of Nephrology (ASN Kidney Week) 2020
Preclinical evaluation of KZR-261, a novel small molecule inhibitor of Sec61
American Society of Clinical Oncology (ASCO 2020)
Blocking Protein Secretion With Novel Small Molecule Inhibitors of Sec61 Represents a Potential Treatment Strategy Against Hematologic Malignancies
American Society of Hematology (ASH 2019)
Proteomic Profiling and Mechanistic Investigating of a Novel Anti-cancer Small Molecule Inhibitor of Sec61
American Society of Hematology (ASH 2019)
